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(57) ABSTRACT 
Disclosed is a method of producing cones and pillars on 
polymethylmethacralate (PMMA) optical fibers for glucose 
monitoring. The method, in one embodiment, consists of 
using electron beam evaporation to deposit a non-contiguous 
thin film of aluminum on the distal ends of the PMMA fibers. 
The partial coverage of aluminum on the fibers is randomly, 
but rather uniformly distributed across the end of the optical 
fibers. After the aluminum deposition, the ends of the fibers 
are then exposed to hyperthermal atomic oxygen, which 
oxidizes the areas that are not protected by aluminum. The 
resulting PMMA fibers have a greatly increased surface area 
and the cones or pillars are sufficiently close together that the 
cellular components in blood are excluded from passing into 
the valleys between the cones and pillars. The optical fibers 
are then coated with appropriated surface chemistry so that 
they can optically sense the glucose level in the blood 
sample than that with conventional glucose monitoring. 
27 Claims, 7 Drawing Sheets 
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PROTECTIVE COATING AND 
HYPERTHERMAL ATOMIC OXYGEN 
TEXTURING OF OPTICAL FIBERS USED 
FOR BLOOD GLUCOSE MONITORING 
ORIGIN OF THE INVENTION 
The invention described herein was made by an employee 
of the United States Government and may be used by or for 
the Government for governmental purposes without pay- 
ment of any royalties thereon or therefor. 
CROSS REFERENCE TO RELATED 
APPLICATIONS 
This application is related to U.S. patent application Ser. 
No. 101942,637 filed Sep. 16, 2004. 
FIELD OF THE INVENTION 
The present invention relates to a sensing device for 
determination of compounds in fluids, and more particularly, 
to a single solid light-conducting fiber comprising the sens- 
ing device with a point of attachment and having a textured 
surface consisting of a distal end having a non-contiguous 
protective coating deposited thereon and being relatively 
uniformly distributed across the textured surface. The pro- 
tective coating is then being further treated by being placed 
in a vacuum system and then subjected to directed hyper- 
thermal beams comprising oxygen ions or atoms. 
BACKGROUND OF THE INVENTION 
The quantification of chemical and biochemical compo- 
nents in aqueous fluids, and particularly in biological fluids, 
such as whole blood or urine and in biological fluid deriva- 
tives such as serum and plasma, is of ever increasing 
importance. Important applications exist in medical diagno- 
sis and treatment and in the quantification of exposure to 
therapeutic drugs, intoxicants, hazardous chemicals and the 
like. These applications include the detection and quantifi- 
cation of an increasing variety of certain circulating anti- 
bodies, cancer-related metabolites, genetically derived 
chemical tracers, and hormones emitted during events such 
as pregnancy. In many instances, the amounts of materials 
being determined are minuscule in the range of a microgram 
or less per deciliter. 
One common medical test is the measurement of blood 
glucose levels by diabetics which is more fully described in 
U.S. Pat. No. 5,859,937 ('937) of H. Nomura and herein 
incorporated by reference. Portions of the teachings of the 
'937 patent are used herein for the sake of completeness. The 
glucose determination, as described in the '937 patent, 
typically entails the diabetic piercing the skin of his or her 
finger with a lance, followed by squeezing or expression of 
a blood droplet. The blood droplet is then transferred to a 
reagent pad or test strip. The amount of blood that is 
conveniently expressed from a finger prick is governed by 
the size and depth of penetration of the lance. Too small a 
nick results in an inadequately sized blood sample for the 
intended analysis. Conversely, too deep a nick results in an 
oversized blood sample. Pain is experienced in the lancing 
procedure, and the degree of pain is associated with the size 
and depth of penetration of the lance. 
The teachings of the '937 patent provides a textured site 
allowing for an increased surface area compared to other 
prior art devices, for use in blood sampling. The increased 
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surface area provides an advantage relating to minimizing 
the invasive feature of glucose testing because the surface 
area being very small, greatly reduces the level of analyte- 
responsive needed to be deposited to perform the glucose 
determination. Increased surface area allows one to utilize a 
small blood droplet, for instance, a droplet having a volume 
of one (1) to five (5) microliters, or preferably 1 to 2.5 
microliters. The '937 patent allows for a reduction relative 
to the prior art thereof, of about one-fifth to about one-tenth 
of the fluid volume necessary blood glucose sensing. It is 
desired that further improvements to the surface area be 
provided, so as to correspondingly reduce the amount of 
blood necessary for determination of glucose for diabetics. 
The '937 patent provides a textured surface using various 
means, such as ion beam sputtering, plasma etching includ- 
ing atomic oxygen plasma, physical abrasion, chemical 
etching, sputtering or ablation by high energy beams, or 
deposition of dendritic-like structures thereon. The textured 
surface of the '937 patent is intended to provide a means for 
separating cellular components in blood from the plasma of 
the blood so as to allow optical sensing of the glucose 
concentration in the blood. The processes described in the 
'937 patent for developing the textured surface need to 
produce a cone or pillar structure at the ends of optical fibers 
or other sensing surfaces which are sufficiently close-so as 
to prevent the cellular components from entering the micro- 
scopic valleys between the cones or pillars so that optical 
sensing of the glucose concentration can be performed. Also, 
it is desired to have a sufficiently high aspect ratio (height to 
width) of cones or pillars to allow sufficient surface area for 
optical determination of the glucose concentration in the 
blood. 
In pursuit for finding desired pillar structures for the 
textured surfaces, some of the different processes mentioned 
in the '937 patent were investigated and may be further 
described with reference to FIG. 1 herein, which illustrates 
a Scanning Electron Microscope image of the end of a 
polymethylmethacrylate optical fiber that was textured by 
the use of thermal energy (c0.5 eV) atomic oxygen through 
salt dust for enhancing texturing. 
The disadvantages of prior art results shown in FIG. 1 is 
that the craters produced were too wide to prevent cellular 
blood components from entering the optical sensing areas 
and the aspect ratio (height to width) of the surface features 
does not offer high gains in surface area relative to flat 
surfaces. As can be seen in FIG. 1, the cone or crater ridges 
are approximately 20-30 microns apart far too much to 
achieve their desired goals. More particularly, the spacing 
between cones or ridges needs to be 5 5 microns to block the 
entry of blood cells into the cone valleys. Thus, the craters 
did not provide separation of the plasma from the blood in 
the areas of the valleys between the cones or pillars where 
optical sensing of the glucose concentration needs to occur. 
Use of thermal energy (c0.5 eV) atomic oxygen, sometimes 
referred to as isotropic thermal energy, to texture the sur- 
faces of clear polymers such as polymethylmethacrylate, 
polystyrene or other hydrocarbon polymer (even with the 
use of small particle salt shielding) causes wide almost 
hemispherical craters to form surface features which are 
only as high as they are wide. The aspect ratio of only 
approximately one (1) requires greater volume blood 
samples than desirable. It is desired that textured surfaces for 
optical sensors used for blood testing be provided that 
provide cones or pillars that are spaced apart from each other 
by less than 5 microns, preferably about 1 micron, and 
having an aspect ratio (height to width) of greater than one 
(1). 
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The previously mentioned related U.S. patent application 
Ser. No. 101942,637 filed Sep. 16, 2004 describes a process 
for providing optical sensors having the desired spacing 
between cones or pillars of less than 5 microns and an aspect 
ratio of greater than one. Although U.S. patent application 
Ser. No. 101942,637 achieves its desired goals, it is further 
desired that an additional process be provided that produces 
optical sensors having a textured surface comprising cones 
or pillars that are spaced apart from each other by less than 
five (5) microns, preferably about 1 micron, and have an 
aspect ratio of greater than one (1) micron. 
Another process related to optical fibers is disclosed in 
U.S. Pat. No. 6,200,737Bl ('737B1) of Walt et a1 that 
employs photolithograph. The cost of using photolithogra- 
phy on the ends of multiple bundle fibers is exceedingly high 
for blood glucose monitoring because it is extremely diffi- 
cult to simply stack a half million of the multiple bundle 
fibers together to be used for blood glucose monitoring and 
perform photolithography thereon as disclosed in the 
'737B1 patent. More particularly, because of the small size 
and the requirement that only short (1-2 cm) lengths need to 
be used for blood glucose monitoring, it would require the 
half million stacking. This stacking can be simplified how- 
ever, as contemplated by the practice of the present inven- 
tion, by using large single fibers where no individual surface 
treatment need be applied. Thus, the cost of the complex 
process of the '737 patent to place surface texture on the 
associated fibers is unnecessarily and disadvantageously 
high. 
OBJECTS OF THE INVENTION 
It is a primary object of the present invention to provide 
a process that creates a sensor having a textured surface 
comprising cones or pillars that are spaced apart from each 
other by less than 5 microns, preferably about 1 micron, and 
having an aspect ratio of greater than one (1). 
Moreover, it is an object of the present invention to 
provide a process for making fine texture, high aspect ratio 
come surface at the distal end of a solid light-conducting 
fiber that is necessary for optical fiber blood glucose moni- 
toring with small blood samples. 
It is a further object of the present invention to provide for 
an optical sensor having cones or pillars that are sufficiently 
close so as to prevent cellular blood components for inter- 
fering with optical sensing of the blood glucose concentra- 
tion. 
Still further, it is an object of the present invention to 
provide a process that creates a textured surface for an 
optical sensing device which has a high surface area that 
correspondingly allows for a reduction in the amount of 
blood needed to be removed from a patient so as to reduce 
the pain to which the patient needs to be subject for glucose 
determination. 
It is a further object of the present invention to provide for 
optical polymer devices serving the sensors that may be used 
for blood plasma diagnostics that require economic separa- 
tion of plasma in the whole blood for optical sensing 
measurements . 
Further still, it is an object to provide optical fibers used 
for blood glucose monitoring without suffering the draw- 
backs of photolithographical processes. 
In addition, it is an object of the present invention to 
provide optical fibers having diameters so as to be suffi- 
ciently sturdy to be conveniently used for blood glucose 
monitoring. 
4 
Further, it is an object of the present invention to provide 
optical fibers having textured surface with desired shapes so 
as to be advantageously used in blood glucose monitoring. 
5 SUMMARY OF THE INVENTION 
The present invention provides for a process and a prod- 
uct produces a solid light-condensing fiber with a point 
attachment and having a distal end possessing a fine texture, 
10 and a high aspect ratio cone surface that provides for optical 
fiber blood glucose monitoring with small blood samples. 
The textured distal end of the solid light-conducting fiber 
has a non-contiguous protective coating first deposited 
thereon and relatively uniformly distributed across the tex- 
15 tured surface. The protective coating is further treated by 
being placed in a vacuum and then subjected to direct 
hyperthermal beams comprising oxygen ions or atoms. 
BRIEF DESCRIPTION OF THE DRAWINGS 
20 
FIG. 1 illustrates a prior art Scanning Electron Micro- 
scope image of the end of an optical fiber that was textured 
by the use of thermal energy (c0.5 eV) atomic oxygen 
through salt dust to enhance texturing; 
FIG. 2 is a prior art schematic view of fibers with textured 
surface sites; 
FIG. 3 is a prior art schematic view of a cone field within 
a textured surface of an optic fiber; 
FIG. 4 is a prior art cross-section of a cone field with the 
FIG. 5 is a composed of FIGS. 5(A) and 5(B), wherein 
FIG. 5(A) is a side section view of the initial acrylic optical 
fiber surface used in the practice of the present invention, 
and FIG. 5(B) is a side section view of the initial acrylic 
35 optical fiber surface of FIG. 5(A) after vapor deposition of 
aluminum serving as the protective coating of the present 
invention; 
FIG. 6 is a block diagram of a process that provides 
hypothermal ionic or atomic oxygen texturing of optical 
FIG. 7 is a side section view of initial acrylic optical fiber 
surface of FIG. 5(A) after vapor deposition of the protective 
coating and atomic oxygen etching; 
FIG. 8 is a block diagram of the apparatus that provides 
FIG. 9 is a Scanning Electron Microscope image of an 
atomic oxygen textured polymethylmethacrylate optical 
fiber that was first coated with aluminum and then textured 
by means of an End Hall atomic or ionic oxygen source 
50 which produces hyperthermal (e1 eV) atomic oxygen ions. 
25 
30 deposited reagent, along with adjacent erythrocyte; 
40 surfaces; 
45 the desired process of the present invention; and 
DETAILED DESCRIPTION OF THE 
PREFERRED EMBODIMENTS 
55 One of the purposes of the present invention is to create 
a surface on optically transparent polymers which has 
closely spaced cones or pillars so as to prevent blood cellular 
components during optical monitoring from entering the 
valleys between the cones or pillars, which would otherwise 
60 interfere with the optical sensing of blood glucose concen- 
tration. It is also a purpose of the present invention to 
produce a high surface area of high aspect-ratio cones or 
pillars which are taller than they are wide so as to enable 
glucose sensing with a minimum volume of blood. The 
65 cellular components in blood predominantly consist of red 
blood cells (erythrocytes of 6.6-7.5 microns diameter) and 
white blood cells (leukocytes such lymphocytes of 8-10 
US 7,382,944 B1 
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microns diameter, neutrophils of 12-15 microns diameter, adjacent to a device for measuring light beam characteristics 
eosinophils of 12-15 microns diameter, basophils of 9-10 of light 20 or 22 emanating from the fibers 10 or 12, 
microns diameter and monocytes of 16-20 microns diam- respectively, after being reflected by the distal end 16. For 
eter). Thus, a 5 micron average spacing between cones or fiber 12, a device 24 may be employed to intercept the 
pillars would serve to prevent the cellular components of 5 returning light beam 22 and reflect the light beam 22 
blood from entering the valleys between the cones and downward, as shown in FIG. 2. When the point of attach- 
pillars which needs to be occupied by the plasma only so as ment 14 is to be adjacent to both the light source and the 
to prevent optical obstruction of the glucose sensing by light device for measuring the light beam characteristics, light 
emitted from the sides of the cones on the textured optical measurement is dependent upon reflection of the light beam, 
fiber end in a manner to be described hereinafter. A further i o  such as light beam 22, by device 24 as shown for fiber 14. 
enhancement is provided by having the spacing between The textured surface 16 may be treated, so as to contain 
cones or pillars be about 1 micron. A high aspect ratio of the an analyte responsive reagent (not shown in FIG. 1). A 
texture (cone height to cone separation) provides a greater chemiluminescent or fluorescent reaction at the textured site 
surface area, thus enabling a smaller volume blood needed 16 resulting from reagent-analyte interactions can be advan- 
to measure glucose concentration. 15 tageously utilized wherein a portion of the chemilumines- 
Another purpose of the present invention is to provide cent or fluorescent light enters the fiber 10 or 12, for 
optically transparent polymer fibers that can be successfully detection and quantitation. The textured surfaces 16 may be 
utilized for blood sampling. The previously mentioned further described with reference to prior art shown in FIG. 
’737B1 patent disadvantageously comprises a bundle of 3. 
multiple fibers whose overall diameter could range from 1 to 20 FIG. 3 provides an enlarged view of a cutaway section of 
50 microns in diameter, which is far too small to be practical a fiber 10 having a textured surface 16. A textured surface 16 
for blood sampling. More particularly, the fibers need to be is schematically depicted in this case as an array of cone- 
able to be held in individual fingers so as to be inserted into shaped projections or pillars 28 defining a cone field 30, 
a readout device, to be further described hereinafter, after which has been formed within the surface 32 of a fiber by 
touching to a small spot of blood. Even the largest bundle of 25 removal of portions of surface 32 and subsurface 34 mate- 
50 microns disclosed in the ’737B1 patent is smaller in rial. Further details of the textured surface 16 may be further 
diameter than an average human hair. Thus, use of such described with reference to prior art in FIG. 4. 
fibers disclosed in the ’737B1 patent would cause one to FIG. 4 shows a representative cross-section 36 of the cone 
easily break them as well as potentially breading them off field 30, wherein a deposit 38 of the analyte-responsive 
(potentially into your skin) when trying to pick up a blood 30 reagent has been conveniently placed within the crevices 
sample on your body. The present invention provides optical between cone projections 28. Also shown in FIG. 4, is a 
fibers that do not suffer the drawbacks of prior art devices. representation of an erythrocyte 40 (a red blood cell), whose 
A still further purpose of the present invention is to size in relationship to the openings between the cones of the 
provide optically transparent polymer fibers having a desired cone field is large, such that it can typically make no more 
shape so as to be utilized for blood sampling. The shape of 35 than incidental contact with the outermost projections of the 
the fibers of ’737B1 patent is approximately hemispherical cones 28. In a determination of a small analyte, such as 
and the fibers are very rounded at their distal ends. This glucose, the reagent deposit 38 within the cone field 30 is 
shape is not useful for optical fibers that monitor glucose readily accessed by the analyte, but protected from the 
level. The reason for this undesired shape is that the purpose erythrocytes 40 based on size selection by the cone field 
of the texture on the end of the fibers is to hold the cellular 40 pattern. Changes in the reagent deposit 38, such as by 
components of the blood from being in contact with the development of a colored complex through reaction with an 
glucose sensing sides of the cones that are interrogated by analyte, is advantageously detected by means of a light beam 
light beams. However, hemispheres allow a large area of (indicated by the arrow 18) being transmitted through the 
contact between the blood cells and the surfaces of the matrix of the fiber. The textured surface 16 is generally in the 
hemispheres. This large contact area may cause a misinter- 45 form of conical or ridge-like structure microns high and 
pretation of the glucose level in the blood because of the wide having a desired aspect ratio (lengthiwide) which is 
light interacting with the blood cells that lie on the surface. preferably greater than one (1). The term “cone field” is 
As will be further described hereinafter, the present inven- herein defined to include textures, which are not necessarily 
tion provides optical fibers having conical surface structures in the specific shape of cones, but may include various 
wherein negligible light reaches the very tip of the cones and 50 linear, box-like or angular arrays of projections so long as 
such interactions have little impact because of the micro- their aspect ratio is greater than one (1). 
scopic contact area. The invention may be further described The analytic-responsive reagent placed between the crev- 
with reference to the prior art shown in FIG. 2. ices of the cones or pillars 28 may be one of many analyte- 
FIG. 2 illustrates two solid light-conducting fibers 10, and sensing systems. In a manner known in the art, for blood 
12 each being transparent, each having a point of attachment 55 glucose determinations, the analyte-sensing system is pref- 
14, and each preferably comprised of a polymer material, erably a composition including a peroxidase enzyme and 
except for silicone. In one embodiment, the fibers 10 and 12 color-generating chemical couplers. Many combinations of 
may be comprised of polymethylmethacralate. Each of the such chemical systems for blood glucose determinations are 
fibers 10, and 12 has a textured surface 16 at the distal end disclosed and described in U.S. Pat. No. 4,935,346, which is 
thereof that is provided by one of the processes of the 60 herein incorporated by reference. For antigens, antibodies, 
present invention to be further described hereinafter with enzymes, enzyme inhibitors, and various other biochemical 
reference to FIGS. 6-9. agents, attachment of affinity ligands to the textured surface 
In one application, at least one end, that is point of 16 may be practiced. Herein, the light traveling through the 
attachment 14, of the light-conductive fibers 10, and 12, is fiber is affected by the development of resulting affinity 
placed adjacent to a light source (not shown) for sending a 65 complexes on the textured fiber surface 16. Alternatively, 
beam of light 18 down the fiber length. The point of chemiluminescent or fluorescent techniques may be utilized 
attachment 14 of each of the fibers 10 and 12 is also located to highlight the affinity attachment of specific biomolecules 
US 7,382,944 B1 
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on the textured surface, a portion of the chemiluminescent or designed to provide a minimally sized droplet, to be further 
fluorescent light being captured and transmitted through the described hereinafter, of blood at a minimized level of 
fiber to a detector. Attachment of ligands to polymeric associated pain. The patient would preferably then touch a 
surfaces through covalent binding is well known in the art of textured site 16 to the droplet, the fiber being advanta- 
affinity membranes. 5 geously pre-fixed to a measurement device. The patient 
In a preferred method of use of the invention, a light- would then read and record his or her blood glucose con- 
conducting fiber, such as 10 of FIG. 2, having a textured site centration determined upon wetout of the textured surface 
16 thereon is located at attachment point 14 adjacent to a site 16 by the minimally sized blood droplet. The minimally 
light source for transmittal of a light beam 18 into the fiber sized droplet is to be further described hereinafter. The 
10, and adjacent also to a device for analysis of light beam i o  preparation of the textured surface 16 is of particular impor- 
characteristics of light beam 20 emanating from an opposite tance to the present invention and will be further described 
end of the fiber 10 after it is reflected by the textured site 16. hereinafter with reference to FIGS. 5-8. 
In a most preferred embodiment, both light input and One of the main contributions of the present invention is 
emanation thereof are at one end of a fiber 10 of predeter- to provide a method of producing cones 28 and pillars, for 
mined length, and the textured site 16 is at an opposite end 15 one embodiment, onpolymethylmethacralate (PMMA) opti- 
of the fiber 10. The textured surface site 16 is first impreg- cal fibers 10 and 12 used for glucose monitoring. In general, 
nated with an analyte responsive reagent, such as a plasma and as will be more fully described hereinafter, the method 
coated analyte. The textured site 16, is then wetted with a comprises using electron beam evaporation to deposit a 
fluid, such as by contacting the fiber at this site with a small non-contiguous protective film on the distal ends 16 of the 
droplet of blood. Interaction of the reagent with the analyte, 20 PMMA fibers 10 and 12 and does not suffer the drawbacks 
if any, present in the fluid is allowed to occur, resulting in an of photolithograph discussed herein in the “Background” 
observable physical or chemical change at the textured site section. The partial coverage of protective coating on the 
16. Light passing through the fiber 10 in the region of the fibers is randomly, but rather uniformly distributed across 
textured site 16 is altered in its characteristics such as the end of the optical fibers 10 and 12. After the protective 
frequency and amplitude, one or more of these changes 25 coating deposition, the distal ends 16 of the fibers 10 and 12 
being detectable and preferably quantifiable by the device are then exposed to hyperthermal atomic oxygen, which 
utilized for analysis of light beam 20 emanating from the oxidizes the areas that are not protected by the protective 
fiber. More particularly, light intercepting the textured sur- coating. The resulting PMMAfibers 10 and 12 have a greatly 
face 16 creates a change in the spectral reflectance as a result increased surface area and the cones 28 or pillars are 
of the light interacting with the plasma-coated analyte 30 sufficiently close together that the cellular components, such 
surface 16. 
As previously mentioned, the diameter of the optical 
fibers 10 and 12 is important to the practice of the present 
invention and it is preferred to be in the range of about 1.0 
mm to about 2.0 mm. This diameter provides a fiber 10 or 
12 that is able to be held in the fingers of an individual, so 
as to be placed in the line of sight of the device utilizing the 
light beam 20 after the textured surface 16 touches a small 
spot of blood. Without the benefits of the present invention, 
the usage of prior art fibers having typical diameters from 1 
as those shown in FIG. 4, in blood are excluded from passing 
into the valleys between the cones 28 and pillars. The optical 
fibers 10 and 12 are then coated with appropriated surface 
chemistry so that the optical fibers 10 and 12 can optically 
35 sense the glucose level in the blood sample, while requiring 
a much smaller blood sample than that with conventional 
glucose monitoring. 
The method used to produce closely-spaced high-aspect 
ratio cones or pillars 28 in optically clear polymers, such as 
40 PMMA, comprises applying a protective film to the distal 
to 50 microns corresponding to the diameter of an average end 16 of the optical fibers 10 and 12. This can be done 
human hair may very likely cause the easy breakage of the relatively quickly (seconds to a few minutes) by a process 
prior art fiber in use, as well as potentially breaking the fibers selected from the group comprising electron beam evapo- 
off (possibly into the skin) when trying to pick-up a blood ration, ion beam sputtering, RF sputtering, and thermal 
sample from the individual for blood glucose monitoring. 45 evaporation, all known in the art. 
As also previously mentioned, the shape of cones of the The protective coating preferably comprises aluminum, 
textured surface 16 of the fibers 10 and 12 that come into but other protective coatings can be applied which simply 
contact with the blood being sampled is important to the have the properties that prevent atomic oxygen from oxida- 
practice of the present invention and is preferably conical. tively eroding them. Other materials may comprise metals 
The reason for the desired conical shape is that the purpose 50 (gold), metal oxides (silicon dioxide), and soluable salts 
of the texture, such as textured surface 16, on the end of the (sodium chloride). In one embodiment, the protective film 
fibers, such as 10 and 12, is to hold the cellular components comprises aluminum having a thickness in the range from 
of the blood from coming in contact with the glucose sensing about 10 microns to about 500 microns. 
sides of the cones that are interrogated by light beams. If The deposition of the protective film may be further 
shapes other than round, such as hemispheres, were used 55 described with reference to FIG. 5. FIG. 5 is composed of 
these shapes would allow a large area of contact between the FIGS. 5(A) and 5(B), wherein FIG. 5(A) is a side section 
blood cells and the surfaces of the hemispheres. This large view of the initial surface 16 of an acrylic optical fiber, such 
contact area may cause a misinterpretation of the glucose as 10 or 12, used in the practice of the present invention, and 
level in the blood because of the light beam 20 interacting FIG. 5(B) is a side section view of the initial surface 16 of 
with the blood cells that lie on the surface. However, for 60 the acrylic optical fiber 10 or 12 of FIG. 5(A) after vapor 
conical surface structures, as provided by the present inven- deposition of aluminum serving as the protective coating of 
tion, negligible light reaches the very tip of the cones 36 and the present invention. FIG. 5 generally illustrates a portion 
such interactions have little impact because of the micro- of protective film with the reference designation 16’ and 
scopic contact area therebetween. shown as being distributed across a portion of the distal end 
As known in the art, a diabetic patient wishing to measure 65 16. The protective film 16’ is comprised of islands shown in 
his or her blood glucose level would pierce the skin of a part with reference designations 16’ (A), 16’ (B), 16’ (C), 16’ 
finger with a lancet whose size and depth of penetration is (D) and 16’ (E) with 16’ (A) and 16’ (D) being large islands 
US 7,382,944 B1 
9 10 
relative to the smaller islands 16' (B), 16' (C) and 16' (E). As 
will be further described with reference to FIG. 8, that after 
the coating 16' is deposited and hyperthermal atomic oxygen 
is used to etch the unprotected areas of the acrylic fibers, the 
gradually eroded away because an end ion Source 
threshold of aluminum. This means that the small aluminum 
islands disappear, such as 16' (B), 16' (C) and 16' (E) leaving 
sharp pointed structures and the large islands, such as 16' (A) i o  
forming a cap thereon. 
selected to deposit the protective film 16', such as electron 
desired vacuum source, which will be further described 
hereinafter with reference to FIG. 8. 
The arrangement 42 of FIG, 6 comprises a DC power 
supply 44 having a preferred range of 25-150 volts, a 
cooling supply 50 preferably being of water and connected 
radiation shield 54, 
aluminum thin protection islands 16' (A) 16' (E) are cathode heater supply 46 connected to a cathode 48, and a 
produces Oxygen ions with energies above the sputter to a water cooling coil 52 arranged with a water-cooled 
The arrangement 42 further comprises a hyperthermal 
atoms or ions that produce a directed beam of energy greater 
than 1 eV and shown as beams 58, 60, or 62 and indicated 
62 can be single or multiply charged, The ion or atomic 
and 16' (D) are made smaller in diameter and thickness thus atomic Oxygen Source 56 that can be Source Of Oxygen 
It is preferred that the vapor provided by the process as 0, O', O,+ respectively, The ions in the beams 58, 60, and 
the protective l5 source 56 can be an End Hall source, an electron bombard- 
merit ion source, a DC plasma source, a microwave plasma 
with uncoated regions 16" between each 16' (A) ' ' ' or any other provided the delivers a 
16' (E). This hyperthermal beam of greater than 1 ,OV comprised of oxy- 
beam evaporation, be thin enough to 
16' to such as 16' (A) ' ' ' 16' (E), 
regions where atomic Oxygen is 
to be protected from the PMMA by the islands 16' (A) . . . 
16' (E) and regions, such as those of 16", where the PMMA 20 
is exposed, so as to be able to be oxidized by atomic oxygen. 
Each exposed region, such as those of 16", have surfaces 
directed beam of energetic atomic oxygen may be further 25 and 62 are preferably directed from one direction onto the 
distal end 16 of each of the light-conducting fibers of the described with reference to FIGS. 6-8. 
bundle 64, so as to produce the textured surface 16 thereon. 
The protective coated regions, such as those coated with the 
'paced high aspect-ratio 'Ones Or pillars 28, as shown in between the cones or pillars 28 to be greater than the natural 
FIG. 9, to be further described hereinafter, in optically clear 30 texture of the fibers and 20, wherein natural texture is the 
polymers consisting Of exposing the surfaces Of the poly- more closely spaced texture that results from directed atomic 
having the non-contiguous protective coating oxygen reactive etching and/or sputter erosion of a polymer, 
16' deposited thereon, to be textured by a directed beam Of Surfaces become microscopica~~y rough as they are eroded 
energetic atomic Oxygen atoms Or ions. The energy Of the 35 by directed beams which is a direct result of statistical 
atomic Oxygen atoms Or ions be hyperthermal (>l erosion processes, known in the art, If the spacing was not 
gen atoms or ions, 
The positive 
connected to an 
Of the DC power supply 44 is 
66 Of the Source 56, whereas the 
comprised of exposed polymers that are textured by a 
directed beam of energetic atomic oxygen atoms or ions, The 
negative 44 is connected 
to the cathode 48. The directed hyperthermal beams 58, 60, 
Of the DC power 
In genera', the arrangements shown in and 
provide One Or more processes used to produce closelyp protective film 16' as shown in FIG, 5, cause the spacing 
ev) so as to produce the textured surfaces shown in 9. 
In the practice of the present invention, it was determined 
that the energy level desired was greater than 1 ev. It was 
further determined that the preferred range was energies in 4o be further described with reference to FIG, 7, 
the range of about 30 eV to about 150 eV. So although it is 
greater than the natural texture, then features of the cones 28 
would often undesirably be too for optimal light 
propagation into the cones 28. The textured surface 16 may 
shows the textured surface 16 as comprising the FIG, 
desired to use energy levels Of greater than 
range Of energies used to 
ev, the typical 
which 
cones 28 that are separated from each other by distance no 
less than 1 micron and have an aspect ratio (lengtWwidth) do the 
work best in terms of high length-to-width cones 28, is in the that is in the range of about to about ,-, As previously 
45 mentioned, after the coating 16' is deposited and hyperther- 30 eV to 150 eV range. 
The reactions, Provided by the Present invention, Produce mal atomic oxygen is used to etch the unprotected areas of 
CloselY-sPaced high aspect-ration cones O r  Pillars. TO Per- the acrylic fibe 0 or 12, the aluminum thin protection 
form this Process, One must Place the optical Polymers, islands 16' (A) 16' (E) are also gradually eroded away 
already having the non-contiguous Protective coating 16' because the end Hall ion source 56 produces oxygen ions 
deposited thereon, to be textured in a vacuum system, which 50 with energies above the sputter threshold of aluminum. This 
evacuated to 5 1x10-~ torr. Without the vacuum system islands 161 (B), 161 (c) and 
atomic and ionic oxygen may be attenuated such as that 16' (E) (shown in FIG, 5(~)) disappear, leaving sharp 
which Occurs at high Pressure, such as air Pressure. An pointed structures as shown in FIG. 7, and the large islands 
energetic ev) beam of atomic oxygen atoms O r  ions is 16' (A) and 16' (D) (shown in FIG. 5(B)) are made smaller 
then formed in the vacuum system by ion O r  atom beam 55 in diameter and thickness thus forming a cap. The end Hall 
accelerating devices, such as End Hall ion accelerators, ion 56 produces ions in the 30 to 150 e~ range at an 
electron bombardment ion thrusters O r  other electrostatic, average of 70 eV, and the sputter threshold (the energy above 
electromagnetic or arc devices, to be further described which ions have enough energy to cause sputter erosion) for 
hereinafter. These different sources need to be able to oxide is in the 10 to 30 ev range, 
Produce Oxygen ion O r  atom energies of greater than 1 eV. 60 Thus, the thin film islands, such as 16' (B), 16' (C) and 16' 
As known in the art, the resulting beams developed from (E) (shown in FIG. 5(B)) gradually sputter away, such that 
the source of greater than 1 eV are directed hyperthermal the small flat top structures will turn into conical structures 
beams. In one embodiment, the ends of a thousand optical and the larger aluminum protective islands, such as 16' (A) 
fibers, already having the non-contiguous protective coating and 16' (D) get smaller and thinner and result in the flat 
deposited thereon, can be treated at one time. An arrange- 65 topped structures that can be seen occasionally in the 
ment 42 of the apparatus for the desired processes is shown scanning electron microscope image along with lots of the 
in FIG. 6, which is devoid, for the sake of clarity, of the smaller pointed structures. 
that the small 
and 
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Thc distancc between the source 56 of FIG. 6 and the 
bundle 64 of optical fiber can be varied from 3 cm to 200 cm 
provided the atom or ion beam 58, 60, and 62 does not 
become depleted by scattering, in a manner known in the art, 
from background oxygen gas molecules in a vacuum cham- 
ber, to be further described hereinafter with reference to 
FIG. 8. The thermal shield 54 is used to prevent sensitive 
optical fibers, such as those comprised in bundle 64, from 
melting. The shield 54 may be a water-cooled shield or may 
comprise a multi-layer insulation or even eliminated if the 
End Hall source 56 uses a hollow cathode and does not 
produce much thermal radiation. For such an arrangement, 
the optical fibers do not need to be relatively close to the End 
Hall source 56, and if the optical fibers are farther away there 
is less cooling needed thereof. 
The bundle 64 is preferably brought together so as to 
provide a hexagonal close-packed array so that the directed 
atomic oxygen or ion beam 58,60, or 62 impinges on the end 
surface of all the fibers at once so as to produce the textured 
surface 16 of all of the fibers making up the bundle 64. The 
atomic oxygen source 56 may cause heating of the optical 
bundle 64. To prevent the heat sensitive polymers, such as 
polymethylmethacrylat from melting, the water cooled or 
thermal-shield chill 54 is inserted between the Ehd Hall 
cathode 66 and the optical fiber bundle 64 as shown in FIG. 
6. 
In general, the length of the cones 28 and the spacing 
between the cones 28, can be varied by simply changing the 
fluence (atomic and ionic oxygen exposure level). The 
length and height have been found to grow in proportion to 
the square root of the fluence (known in the art). The vacuum 
source in which the bundle 64 of solid light-conducting 
fibers are placed before being subjected to the hyperthermal 
beams 58,60, or 62, may be further described with reference 
to FIG. 8. 
FIG. 8 shows a vacuum source 72 having a door 74 
through which the bundle 64 of fibers may be entered. The 
vacuum source 72 can be any configuration that allows 
evacuation down to a pressure of less than l ~ l O - ~  torr
during atomic oxygen operation. 
The vacuum source 72 shows provisions of a roughing 
pump 76 that provides an output to a blower pump 78 which, 
in turn, provides an output source of air to valves 80 and 82, 
all in a manner known in the art. The valve 80 directs its 
output into the vacuum source 72 by way of gate valve 84, 
whereas the valve 82 directs its output into a diffusion pump 
86 (also known in the art). 
The diffusion pump 86 receives heat from a heat supply 
88 by way of elements 90 and 92. The diffusion pump 86 
also receives cooling (LN,) by means of a liquid nitrogen 
cooled trap 94. 
The apparatus of FIG. 8, using conventional elements, 
provides for one method of the present invention that causes 
a solid light-conducting fiber used in the analyses of blood 
and to have a desired textured surface 16 by first placing the 
solid light-conducting fibers 10 or 12 having the distal end 
16 in a vacuum source 72 and then subjecting the distal end 
16 to directed hyperthermal beams 58,60, or 62 comprising 
oxygen atoms or ions. The operation of the apparatus of FIG. 
8 provides for textured surface 16, which may be further 
described with reference to FIG. 9. 
12 
Hall atomic or ionic oxygen source provided by the appa- 
ratus of FIG. 8. FIG. 9 shows that the separation between 
pillars and cones is 5 1 micron and extremely thus suitable 
to prevent the cellular components 40 of blood, such as that 
5 shown in FIG. 4, from entering the valleys between the 
cones or pillars 28 as shown in FIG. 4. In addition, the aspect 
ratio of the fibers is much greater than 1, far better than the 
aspect ratio of less than one (1) achieved by the thermal 
energy atomic oxygen texturing shown in FIG. 1. 
One of the primary advantage of the present invention, 
relating to its minimally invasive feature, is the presence of 
a large surface area in a very small, localized area, by which 
a greatly increased level of analyte-responsive reagent can 
be deposited and maintained. As more fully described in the 
15 previously incorporated by reference '937 patent, the large 
surface area disclosed in the '937 patent allows for the 
accommodation of blood samples preferably in the range of 
1.0 to 2.5 microliters. Based on the practice of the present 
invention, a ratio of 2 to about 6 increase in effective area 
20 relative to the teaching of the '937 patent is achieved which, 
in turn, decreases the amount of blood sample required by a 
factor of 2 to about 6. Thus, the practice of the present 
invention accommodates a blood sample in the range from 
about 0.5 to 1.25 microliters to about from 0.16 to about 
It should now be appreciated that the practice of the 
present invention first places a places a protective coating of 
the distal end of an optical fiber and then uses directed 
hyperthermal equal or greater than 1 eV beams comprising 
30 oxygen atoms or ions to produce textured surfaces 16. The 
present invention also provides for the thermal radiation 
shielding to prevent overheating of the textured surfaces, 
while at the same time, one embodiment uses an End Hall 
atomic or ionic oxygen source, having a hollow cathode, and 
35 providing for texturing optical polymer surfaces without the 
use of thermal shielding. 
The present invention makes use of the natural formation 
of cones or pillars that result when the distal end of an 
optical fiber has a protective coating deposited thereon and 
40 then the distal end is subjected to direct hyperthermal 
(greater than 1 eV) atomic or ionic oxidation. The apparatus 
of the present invention allows these cones or pillars 28 to 
be sufficiently close or spaced, so as to prevent cellular blood 
components from interfering with optical sensing of blood 
45 glucose concentration. The present invention also provides 
for small samples of blood to be used as compared to the 
previous prior art sensors performing the same task. 
While the present invention has been described more 
particularly in the context of glucose determinations and 
50 whole blood by diabetics, the invention may be utilized in 
the determination of other analytes as well, or as even 
simultaneous determination of two or more analytes. 
While the preferred invention is presently contemplated 
that has been shown in the drawing as described herein, 
variations of preferred embodiments will be apparent to 
those skilled in the art and the invention should not be 
construed as limited to the specific forms as shown and 
described herein, but rather set forth in the following claims. 
10 
25 0.41. 
55 
60 
What I claim is: 
FIG. 9 shows a Scanning Electron Microscope image of 1. A sensor comprising a single solid light-conducting 
an atomic oxygen textured polymethylmethacrylate optical fiber having a textured surface site consisting of a textured 
fiber that first had a non-contiguous protective coating 16' distal end first having a non-contiguous protective coating 
deposited on its distal end 16. The distal end 16 having the 65 deposited thereon which is treated by being placed in a 
protective coating 16' was then textured by the practice of vacuum and then subject to directed hyperthermal beams 
the present invention by using a hyperthermal (>1 eV) End comprising oxygen ions or atoms, wherein said textured 
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distal end comprises said non-contiguous protective coating 
thereon and cones separated from each other by an amount 
which is about 1 micron. 
2. The sensor according to claim 1, wherein said protect- 
ing coating is of a material selected from the group com- 5 
prising aluminum, gold, silicon dioxide and sodium chlo- 
ride. 
3. The sensor according to claim 2, wherein said alumi- 
num has a thickness in the range from about 10 microns to 
about 500 microns. 10 
4. The sensor according to claim 1, wherein said single 
solid light-conducting fiber has a diameter in the range from 
about 1.0 nun to about 2.0 nun. 
5. The sensor according to claim 1, wherein said textured 
distal end comprises cones having a length to width ratio, 15 
which is greater than one. 
6. The sensor according to claim 5, wherein said cones 
have a conical shape. 
7. The sensor according to claim 1, wherein an analyte- 
responsive reagent is deposited on said fiber at said textured 20 
surface site. 
8. The sensor according to claim 1, wherein said light- 
conducting fiber is transparent and is of polymer material 
except for silicone. 
conducting fiber is polymethylmethacralate. 
used in the analysis of a blood comprising the steps of 
9. The sensor according to claim 8, wherein said light- 25 
10. A method of producing a solid light-conducting fiber 
a) selecting at least one single solid light-conducting fiber 
b) depositing a protective coating on said distal end of 
said at least one light-conducting fiber; 
c) placing said at least one light-conducting fiber having 
said protective coating on said distal end in a vacuum 
source; and 35 
d) subjecting said distal end to directed hyperthermal 
beams comprising oxygen ions or atoms. 
11. The method according to claim 10, wherein said 
protective coating is of a material selected from the group 
comprising aluminum, gold, silicon dioxide, and sodium 40 
chloride. 
12. The method according to claim 11, wherein said 
aluminum has a thickness in the range from about 10 
microns to about 500 microns. 
13. The method according to claim 10, wherein said single 45 
light-conducting fiber is polymethylmethacralate. 
14. The method according to claim 10, wherein said single 
solid light-conducting fiber has a diameter in the range from 
about 1.0 nun to about 2.0 nun. 
vacuum source supplies a pressure of less than about l ~ l O - ~  
while said distal end is being subjected to said directed 
hyperthermal beams comprising ions or atoms. 
16. The method according to claim 10, wherein said 
directed hyperthermal beams have an energy level that is in 55 
the range from about greater than 1 eV to about 100 eV. 
17. The method according to claim 16, wherein said 
directed hyperthermal beams is in the range from about 30 
eV to about 150 eV. 
having a point of attachment and a distal end; 30 
15. The method according to claim 10, wherein said 50 
14 
18. The method according to claim 10, wherein said 
directed hyperthermal beams comprising oxygen ions or 
atoms are provided from a source selected from the group 
consisting of an End Hall source, an electron bombardment 
ion source, a microwave plasma source and an arc source. 
19. The method according to claim 18, wherein said 
selected source and said distal end are spaced apart from 
each other by a distance in the range from about 3 cm to 
about 200 cm. 
20. The method according to claim 19, wherein said at 
least one solid light-conducting fiber comprises a plurality 
arranged in a bundle and each having a distal end. 
21. The method according to claim 20, wherein said 
selected source and said bundle has a shield interposed 
therebetween and wherein said selected source and said 
distal ends of said bundle are spaced apart from each other 
by a distance in the range from about 3 cm to about 200 cm. 
22. The method according to claim 21, wherein said shield 
is selected from the group consisting of a water-cooled 
shield and multilayer insulation shield. 
23. The method according to claim 18, wherein said 
source is an End Hall source having a hollow cathode and 
separated from said distal ends of said bundle by a distance 
in the range from about 3 cm to about 200 cm. 
24. A method of analyzing for an analyte in a fluid 
comprising the steps of 
providing a single solid light-conducting fiber with a point 
of attachment and having a distal end with a protective 
coating deposited thereon and wherein said protective 
coating is further prepared by being placed in a vacuum 
and then subjected to directed hyperthermal beams 
comprising oxygen ions or atoms, said distal end fur- 
ther having an analyte-responsive reagent deposited 
thereon; 
bringing a droplet of the fluid containing said analyte and 
having an initial sampling volume of less than 5 
microliters into contact with said distal end of said site, 
so as to produce a physical or chemical response by 
interaction of said reagent with said analyte, said 
response being detectable by a change in characteristics 
of a light beam; 
transmitting a light beam from a light source into said 
point of contact and into said distal end; and 
analyzing said light beam reflected from said distal end 
for said change, said change being correlative with 
presence of said analyte in the fluid. 
25. The method according to claim 24, wherein said 
change is correlative with the concentration of said analyte 
in the fluid. 
26. The method according to claim 25, wherein the fluid 
being brought into contact with said fiber has an initial 
sampling volume of about 0.2 to about 0.4 microliters. 
27. The method according to claim 26, wherein the fluid 
is blood and the analyte is glucose. 
* * * * *  
